Key Takeaways Danish pharmaceutical giant Novo Nordisk is set to report earnings for the third quarter of 2024 on Wednesday morning.Sales of its popular weight-loss drugs Ozempic and Wegovy will be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback